Provided by Tiger Fintech (Singapore) Pte. Ltd.

Opthea Ltd

3.41
+0.0000
Volume:- -
Turnover:- -
Market Cap:524.84M
PE:-1.62
High:3.41
Open:3.41
Low:3.41
Close:3.41
Loading ...

Ocean Power Technologies Secures $2 Million in Purchase Orders for PowerBuoys® in Latin America

GlobeNewswire
·
31 Jan

Is Opthea Limited (OPT) One of the Best ASX Stocks to Buy According to Hedge Funds?

Insider Monkey
·
31 Jan

Opthea Limited: Promising Outlook with Sozinibercept in wAMD and Pivotal Trials on Track

TIPRANKS
·
30 Jan

Broker Upgrades: Canaccord says disease specialist Opthea could triple if Phase III trial passes muster

Stockheads
·
29 Jan

Phase III Trials: It’s crunch time for these ASX health stocks

Stockheads
·
29 Jan

Promising Investment Opportunity in Opthea’s Sozinibercept for Wet AMD Treatment

TIPRANKS
·
29 Jan

Opthea Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
29 Jan

Innovative Approach and Strategic Positioning Drive Buy Rating for Opthea Limited Sponsored ADR

TIPRANKS
·
29 Jan

Opthea Unveils Promising Wet AMD Therapy at Investor Day

TIPRANKS
·
29 Jan

Why Opthea (OPT) Is Among the Best Australian Stocks to Buy Now?

Insider Monkey
·
27 Jan

RBC Capital Reaffirms Their Buy Rating on Optima Health PLC (OPT)

TIPRANKS
·
22 Jan

Analysts’ Opinions Are Mixed on These Healthcare Stocks: GlaxoSmithKline (GB:GSK), CSL (OtherCMXHF) and Opthea Limited (OtherCKDXF)

TIPRANKS
·
21 Jan

Optima Health Director Increases Shareholding

TIPRANKS
·
20 Jan

Why this speculative ASX stock could rocket 70%

MotleyFool
·
16 Jan

Bell Potter Sticks to Its Buy Rating for Opthea Limited (CKDXF)

TIPRANKS
·
15 Jan

Opthea’s Innovative Approach to AMD Treatment with Sozinibercept

TIPRANKS
·
13 Jan

Optimistic Buy Rating for Opthea Limited: Sozinibercept’s Promising Phase 3 Potential and Market Positioning

TIPRANKS
·
11 Jan

Top 3 Australian High Growth Tech Stocks to Watch

Simply Wall St.
·
10 Jan

Opthea to Host Investor Days in New York and Australia

GlobeNewswire
·
08 Jan

Opthea to Host Investor Days Highlighting Sozinibercept’s Potential in Wet AMD

TIPRANKS
·
08 Jan